Welcome : Guest

Theratechnologies, Inc. (Canada) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Theratechnologies, Inc., which is principally involved in Specialty Pharmaceuticals Business. Illustrated with 10 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-44313
Price: $500
Company Type: Public
Pages: 12
Date: November 2016
Market Data Tables: 10

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Theratechnologies, Inc.'s Sales by Customers (2015) in Percentage for RxCrossroads, and Others......3
HIV Drugs......4
Table 2: HIV Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)/ Nucleoside Reverse Transcriptase Inhibitor (NRTI) Fixed Dose Combination (FDC), Nucleoside Reverse Transcriptase Inhibitor (NRTI)/Retroviral Integrase/CYP3A, Nucleoside Reverse Transcriptase Inhibitor (NRTIs), Protease Inhibitors, Retroviral Integrase (IN), and Others* (Includes NNRTIs)......4
Table 3: HIV Regimens for New Start Patients by Segment in European Union (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......5
Table 4: HIV Regimens for Experienced Patients by Segment in the US (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Stribild, Truvada and Others......6
Table 5: HIV Regimens for New Start Patients by Segment in the US (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......7
Speciality Pharmaceuticals......8
Table 6: Speciality Pharmaceuticals Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......8
Table 7: Specialty Pharmaceuticals Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Hepatitis, HIV & AIDS (including oral solids), Intravenous Immunoglobulin (Hemophilia), Multiple Sclerosis, Oncology (including oral solids), Renal, Rheumatoid Arthritis (Crohn's), and Others......9
Speciality Drugs......10
Table 8: Speciality Drug Sales by Therapeutic Category in the US (2015) - Percentage Market Share Breakdown by Value for Anticoagulants, Cancer, Growth Deficiency, Hepatitis C, HIV, Inflammatory Conditions, Multiple Sclerosis, Pulmonary Hypertension, Respiratory Conditions, Transplant and Others......10
HIV Point-of-Care Testing......11
Table 9: HIV Point-of-Care Testing Market by Type in the US (2015) - Percentage Share Breakdown by Value for Chembio Blood, Orasure Blood, Orasure Saliva, and Others......11
Rapid Testing Equipment (HIV)......12
Table 10: Market Shares of Leading HIV Rapid Testing Equipment Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Bio-Rad Laboratories, Inc. (BIO), Chembio Diagnostics, Inc. (CEMI), OraSure Technologies, Inc. (OSUR), Trinity Biotech Plc (TRIB), and Others......12